During the past decade, Shakespeare Specialist Group conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shakespeare Specialist Group" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Shire" with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Shakespeare Specialist Group" are "Ulcerative Colitis" (6 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Shakespeare Specialist Group" in a lesser frequency.

Most popular intervention types in "Shakespeare Specialist Group" are "Drug" (10 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (5 trials), "Placebo" (3 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Asacol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shakespeare Specialist Group" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Shakespeare Specialist Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Shakespeare Specialist Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shakespeare Specialist Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".